Disease
Disease

Beacon Biosignals is mapping the brain during sleep

Founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels, the company is creating an AI-driven platform to help diagnose and treat disease.

3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs

Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.

Five with MIT ties elected to National Academy of Medicine for 2025

Professors Facundo Batista and Dina Katabi, along with three additional MIT alumni, are honored for their outstanding professional achievement and commitment to service.

Helping scientists run complex data analyses without writing code

Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.

AI maps how a new antibiotic targets gut bacteria

MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.

MIT researchers develop AI tool to improve flu vaccine strain selection

VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.

Using generative AI, researchers design compounds that can kill drug-resistant bacteria

The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.

How to more efficiently study complex treatment interactions

A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.

With AI, researchers predict the location of virtually any protein within a human cell

Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.

MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease

ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.